BCTX
Briacell Therapeutics Corp
NASDAQ: BCTX · HEALTHCARE · BIOTECHNOLOGY
$4.18
+3.98% today
Updated 2026-04-30
Market cap
$28.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-14.42
Dividend yield
—
52W range
$4 – $50
Volume
0.2M
Briacell Therapeutics Corp (BCTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-179.20%
ROA
-89.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-8580.00 | — | — | — |
| 2007 | — | $-116406.00 | — | — | — |
| 2008 | — | $-98926.00 | — | — | — |
| 2009 | — | $-245831.00 | — | — | — |
| 2010 | — | $-927694.00 | — | — | — |
| 2011 | — | $-1.03M | — | — | — |
| 2012 | — | $-998987.00 | — | — | — |
| 2013 | — | $-381983.00 | — | — | — |
| 2014 | — | $-8.90M | — | — | — |
| 2015 | — | $-3.49M | — | — | — |
| 2016 | — | $-2.23M | — | — | — |
| 2017 | — | $-3.22M | — | — | — |
| 2018 | $0.00 | $-5.41M | — | — | — |
| 2019 | $0.00 | $-5.82M | — | — | — |
| 2020 | $0.00 | $-4.94M | — | — | — |
| 2021 | $0.00 | $-17.63M | — | — | — |
| 2022 | $0.00 | $-34.13M | — | — | — |
| 2023 | $0.00 | $-27.27M | — | — | — |
| 2024 | $0.00 | $-6.55M | — | — | — |
| 2025 | — | $-36.50M | — | — | — |